Effect of Insulin and Losartan on Modulation of Insulin-Like Growth Factor 1 Receptor at Heart Level in Diabetic Rats

• Published in: The open drug delivery journal 2007-12, Vol.1 (1), p.1-6
• Main Authors: Bikhazi, Anwar B., Maharsy, Wael M., Kadi, Lina N., Issa, Nahla G., Barakat, Ghinwa M., Nuwayri-Salti, Nuha, Karam, George K., Batal, Omar A., Bitar, Khalil M.
• Format: Article
• Language: English
• ISSN: 1874-1266; 1874-1266
• DOI: 10.2174/1874126600701010001

This study investigates insulin-like growth factor-1 receptor (IGF-1R) modulation in hearts of streptozotocin-induced diabetic rats treated with insulin/angiotensin-II receptor subtype-1 blocker (AR sub(1B), losartan. Male rats were divided into: normal (N), losartan-treated normal (NL), diabetic (D), insulin-treated diabetic (DI), losartan-treated diabetic (DL), and insulin/losartan co-treated diabetic (DIL) groups. Thirty days post-treatment, rats underwent heart perfusion using [I) super(1)25]-labeled IGF-1 to assess receptor-binding affinity on coronary endothelial cells (CE) and cardiomyocytes (CM). This revealed an increase in binding affinity of IGF-1 to its receptor on CE in all groups compared to N. On CM, binding affinity increased in D, DI, and DL compared to N, but was almost normalized in DIL. Western blot analyses and immunohistochemistry done on heart tissues showed decrease in IGF-1R density in DIL versus remaining groups. These results demonstrate a complex interaction between insulin, angiotensin-II, and IGF-1, and mass blockade of myocardial remodeling by AR sub(1B treatment in diabetic state.)